HP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Helmerich and Payne is not a good buy right now for a Beginner investor with a long-term horizon and $50,000-$100,000 to deploy. The stock has supportive analyst sentiment and a constructive strategic catalyst, but the technical picture is mixed-to-weak in the near term, insider and hedge fund selling is heavy, and there is no strong proprietary buy signal today. If the investor is impatient and wants to enter now rather than wait, this is still not the best risk-reward entry.
HP is trading pre-market at 39.61, just above the pivot level of 39.123. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports the broader trend. However, momentum is not confirming strength: MACD histogram is negative and expanding, and RSI_6 at 47.867 is neutral. Resistance sits at 41.354 and 42.732, while support is at 36.892 and 35.514. The setup suggests the longer-term trend is improving, but near-term momentum is still weak and the stock is not showing a clean breakout signal.
["Baker Hughes and Helmerich & Payne announced a strategic partnership to support geothermal exploration and development in the U.S.", "Analyst targets have been trending higher across several firms, with BofA, Piper Sandler, Susquehanna, Barclays, and Evercore all raising targets recently.", "Barclays and Evercore highlighted a favorable multi-year setup for energy services tied to tighter oil supply and improving upstream spending.", "Bullish moving average structure suggests the medium-term trend is improving."]
["Hedge funds are selling aggressively, with selling up 5577.59% over the last quarter.", "Insiders are also selling aggressively, with selling up 1701.59% over the last month.", "MACD momentum is negative and worsening.", "Historical pattern data suggests downside tendency over the next day, week, and month.", "No AI Stock Picker or SwingMax signal is present today."]
No financial snapshot was available because the latest quarter data could not be parsed. As a result, there is no reliable quarter-over-quarter revenue or earnings growth assessment from the provided dataset. The latest quarter season was not provided in the usable financial data.
Analyst sentiment is positive overall, with several target hikes: BofA to $44 with a Buy rating, Piper Sandler to $43 with an Overweight rating, Susquehanna to $43 with a Positive rating, Barclays to $47 with an Overweight rating, and Evercore to $43 with an Outperform rating. Morgan Stanley remains the main cautious view with an Underweight rating, though it still raised its target to $39. The Wall Street pros view is constructive on the sector and medium-term fundamentals, while the con view is that valuation and execution remain less compelling enough to justify a strong immediate buy.
